Winstead has experience in a wide range of transactions, regulatory compliance, and dispute resolution matters involving the growing and dynamic healthcare business sector. We seek creative solutions to the difficult issues our clients face. We deploy the resources of our integrated firm, with a strategic combination of big-picture perspective and industry-specific technical and tactical knowledge.
We represent hospitals, ambulatory surgery centers, physician groups, home health agencies, senior living and long term care facilities, wellness companies, third party administrators, pharmaceutical manufacturers, medical device manufacturers and various healthcare facilities, vendors and business entities on transactions, litigation, government investigations, and corporate and regulatory healthcare issues.
Our attorneys know the healthcare business is highly regulated at federal and state levels. We handle a range of statutory and regulatory issues including compliance matters relating to HIPAA, the HITECH Act, and final Omnibus Rules with regard to privacy and security. We counsel our clients on the Stark Law, Anti-Kickback Statute, state anti-referral and fraud and abuse laws, facility licensure, accreditation and governance; Medicare and Medicaid reimbursement; managed care contracting; and Affordable Care Act legislation.
We represent healthcare clients before federal, state and local governments, positioning their concerns at the forefront of the agendas of legislative and regulatory decision makers. Our achievements include securing federal appropriations for non-profit health research institutions.
Our corporate lawyers play key roles in representing healthcare clients in their business transactions. We have first-hand knowledge and experience in the healthcare industry and deliver a practical, hands-on approach to closing deals without overlawyering the process. Matters regularly handled by these attorneys include entity formations and capitalizations; tax planning; private placements; recapitalizations; financings and refinancings; and acquisitions, dispositions and other liquidity transactions. Our health law attorneys regularly conduct healthcare due diligence for business transactions or in support of a client's corporate counsel.
We represent hospitals, healthcare systems, physician groups, developers, senior living and long term care facilities, investors and operators in a wide range of health care real estate transactions, including the development, acquisition, financing and disposition of acute and non-acute real estate assets on a national platform. We assist our hospital clients in structuring hospital campus transactions, including counseling them on control issues, monetization structures and physician alignment strategies. Our Healthcare Facilities Real Estate Practice also includes land use planning, economic development, project finance, construction and leasing (including ground leases, space leases and build-to-suit transactions for healthcare facilities). Whether representing the provider or the user, we bring a unique blend of real estate excellence and health care industry acumen to each transaction.
Find out more about Winstead's Healthcare Facilities Real Estate Practice
Our administrative law attorneys handle a variety of matters on behalf of our healthcare clients before the Texas Department of Insurance, the Texas Attorney General, and other administrative bodies. Our longstanding relationships with governmental authorities provide our clients with unique accessibility to agencies important to healthcare industry participants. As a result, we offer our clients a range of solutions that align business interests and public policy.
Winstead attorneys advise our healthcare clients on all aspects of employee-employer relationships. Conflict prevention is a major component of our practice; however, when disputes do arise, we help our clients minimize risks by ensuring regulatory compliance and protecting our clients' interests.
Representing our healthcare clients in business litigation is a significant portion of our practice. We leverage the knowledge, resources, and experience of our full-service business law firm with a litigation bench of 50 attorneys strong. When litigation is necessary, we work vigorously to protect our clients' rights and interests, while helping evaluate, manage, and control the risks, costs, and uncertainties associated with litigation.
Powering innovations in information technology, biotechnology and life sciences, Winstead helps clients make the most of their investments, ideas and inventions. From small start-ups to integrated corporations, Winstead’s biotechnology attorneys address and understand each stage of company growth. We counsel biotech innovators, organizations and investors through a wide range of phases and issues. We advise pharmaceutical manufacturers, software vendors and medical device companies on their interactions with healthcare providers and governmental healthcare programs. Our health law attorneys assist healthcare providers to evaluate and negotiate electronic health records and outsourced information technology agreements.
Our benefits and compensation attorneys work closely with our healthcare clients on the development and implementation of all types of traditional benefit plans, including qualified and non-qualified retirement programs and consumer-driven healthcare programs. Furthermore, we assist our healthcare clients in administering their benefit programs and maintaining regulatory compliance. In addition, we develop and advise on innovative strategies to attract, retain and motivate talent to ensure our clients’ overall success.
Our healthcare lending attorneys represent lenders in bilateral and syndicated transactions involving loans to hospitals, medical service providers, medical clinics, senior care facilities and other industry related companies. We represent lenders in real estate loans for senior care, medical clinics and nursing facilities. We also represent senior lenders in healthcare loans involving complex capital structures and intercreditor issues including 2nd lien financing, mezzanine financing and equity sponsored transactions.